JAK inhibitors: risks and safety principles An overview of the mechanism of action of Janus kinases inhibitors, as well as the risks and common side effects of their use in treating chronic inflammatory disorders.…
Health news round-up: puberty blockers, oral GLP-1s and inequalities in neonatal care A weekly summary of important developments in pharmacy and health news that you may have missed.…
NICE recommends first licensed treatment for vitiligo Guidance says that ruxolitinib cream can be used as treatment for vitiligo if other first-line treatments — such as including topical corticosteroids and light therapy — do not work.…
Two-prescriber sign-off no longer required for isotretinoin The Medicines and Healthcare products Regulatory Agency said that scrapping the two-prescriber requirement will address delays in access to acne treatment for patients aged under 18 years old.…
‘Balanced’ guidance on isotretinoin welcomed as MHRA launches survey The Commission on Human Medicines-endorsed updates to isotretinoin guidance encourages patients to ask about mental health or sexual dysfunction side effects associated with the drug in follow-up consultations.…
Test your knowledge of dermatological conditions One in four people in England and Wales visit their GP about a dermatological condition each year. Here, test your knowledge of these common conditions and their management.…
Hidradenitis suppurativa: identification, symptoms and management How to recognise the signs and symptoms of this chronic skin condition, with advice on pharmacological management.…
Safety measures introduced for isotretinoin prescribing in patients aged under 18 years Recommendations to improve the safety of prescribing the acne drug isotretinoin have been made by the Commission on Human Medicines.…
Shortage of scabies treatment ‘likely to become a major public health issue’ The government has issued a medicine supply notification warning that permethrin 5% w/w cream will be “in limited supply until further notice due to an increase in demand”.…
Two prescribers must agree that acne is ‘severe enough’ before under-18s are prescribed isotretinoin, review concludes The Commission on Human Medicines' recommendations will be taken forward by the Medicines and Healthcare products Regulatory Agency to support the acne drug's safe use.…
